These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 2898341)

  • 1. Disposition and metabolism of double-labeled [3H and 14C] N-methyl-2-pyrrolidinone in the rat.
    Wells DA; Digenis GA
    Drug Metab Dispos; 1988; 16(2):243-9. PubMed ID: 2898341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition of N-vinyl-2-pyrrolidinone in the rat.
    McClanahan JS; Lin YC; Digenis GA
    Drug Chem Toxicol; 1984; 7(2):129-48. PubMed ID: 6434280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous absorption of co-administered N-methyl-2-[14C]pyrrolidinone and 2-[14C]pyrrolidinone in the rat.
    Midgley I; Hood AJ; Chasseaud LF; Brindley CJ; Baughman S; Allan G
    Food Chem Toxicol; 1992 Jan; 30(1):57-64. PubMed ID: 1544607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute intravenous and inhalation pharmacokinetics of 2,4-pentanedione in the Fischer 344 rat.
    Frantz SW; Ballantyne B; Leung HW
    Toxicol Ind Health; 1998; 14(3):413-28. PubMed ID: 9569447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition of the 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats.
    Cossum PA; Sasmor H; Dellinger D; Truong L; Cummins L; Owens SR; Markham PM; Shea JP; Crooke S
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1181-90. PubMed ID: 8166890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
    Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
    Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue distribution and excretion of N-methyl-2-pyrrolidone in male and female rats.
    Sitarek K; Kilanowicz A
    Int J Occup Med Environ Health; 2006; 19(2):142-8. PubMed ID: 17128812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition of MK-852, a fibrinogen receptor antagonist, in rats and dogs.
    Vickers S; Duncan CA; Yuan AS; Vyas KP
    Drug Metab Dispos; 1994; 22(4):631-6. PubMed ID: 7956740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of MK-499, a class III antiarrhythmic agent, in rats and dogs.
    Vickers S; Duncan CA; Slaughter DE; Arison BH; Greber T; Olah TV; Vyas KP
    Drug Metab Dispos; 1998 May; 26(5):388-95. PubMed ID: 9571219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Route-dependent comparative metabolism of [14C]toluene 2,4-diisocyanate and [14C]toluene 2,4-diamine in Fischer 344 rats.
    Timchalk C; Smith FA; Bartels MJ
    Toxicol Appl Pharmacol; 1994 Feb; 124(2):181-90. PubMed ID: 8122263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the pharmacokinetics and metabolism of 4-chlorodiphenyl ether in rats.
    Chui YC; Addison RF; Law FC
    Drug Metab Dispos; 1987; 15(1):44-50. PubMed ID: 2881758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of [14C]nonoxynol-9 after intravenous or vaginal administration to female Sprague-Dawley rats.
    Walter BA; Agha BJ; Digenis GA
    Toxicol Appl Pharmacol; 1988 Nov; 96(2):258-68. PubMed ID: 2848334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue distribution, disposition, and metabolism of cyclosporine in rats.
    Wagner O; Schreier E; Heitz F; Maurer G
    Drug Metab Dispos; 1987; 15(3):377-83. PubMed ID: 2886315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat.
    Sauer JM; Smith RL; Bao J; Kattnig MJ; Kuester RK; McClure TD; Mayersohn M; Sipes IG
    Drug Metab Dispos; 1997 Jun; 25(6):732-9. PubMed ID: 9193875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of 14C- and 3H-labeled ziprasidone.
    Prakash C; Kamel A; Anderson W; Howard H
    Drug Metab Dispos; 1997 Feb; 25(2):206-18. PubMed ID: 9029052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The metabolic disposition of 14C-labelled carmoisine in the rat after oral and intravenous administration.
    Galli CL; Marinovich M; Costa LG
    Food Chem Toxicol; 1982 Aug; 20(4):351-6. PubMed ID: 6890016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentrations of N-methyl-2-pyrrolidone (NMP) and its metabolites in plasma and urine following oral administration of NMP to rats.
    Carnerup MA; Saillenfait AM; Jönsson BA
    Food Chem Toxicol; 2005 Sep; 43(9):1441-7. PubMed ID: 15951091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.